These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 17948025)

  • 1. Non-coding transcripts in the H19 imprinting control region mediate gene silencing in transgenic Drosophila.
    Schoenfelder S; Smits G; Fraser P; Reik W; Paro R
    EMBO Rep; 2007 Nov; 8(11):1068-73. PubMed ID: 17948025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CTCF binding at the H19 imprinting control region mediates maternally inherited higher-order chromatin conformation to restrict enhancer access to Igf2.
    Kurukuti S; Tiwari VK; Tavoosidana G; Pugacheva E; Murrell A; Zhao Z; Lobanenkov V; Reik W; Ohlsson R
    Proc Natl Acad Sci U S A; 2006 Jul; 103(28):10684-9. PubMed ID: 16815976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polycomb-group proteins are involved in silencing processes caused by a transgenic element from the murine imprinted H19/Igf2 region in Drosophila.
    Erhardt S; Lyko F; Ainscough JF; Surani MA; Paro R
    Dev Genes Evol; 2003 Jul; 213(7):336-44. PubMed ID: 12750886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Igf2/H19 imprinting control region (ICR): an insulator or a position-dependent silencer?
    Banerjee S; Smallwood A; Lamond S; Campbell S; Nargund G
    ScientificWorldJournal; 2001 Jun; 1():218-24. PubMed ID: 12806090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The human and mouse H19 imprinting control regions harbor an evolutionarily conserved silencer element that functions on transgenes in Drosophila.
    Arney KL; Bae E; Olsen C; Drewell RA
    Dev Genes Evol; 2006 Dec; 216(12):811-9. PubMed ID: 17016732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CTCF binding at the insulin-like growth factor-II (IGF2)/H19 imprinting control region is insufficient to regulate IGF2/H19 expression in human tissues.
    Ulaner GA; Yang Y; Hu JF; Li T; Vu TH; Hoffman AR
    Endocrinology; 2003 Oct; 144(10):4420-6. PubMed ID: 12960026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imprinting and gene silencing in mice and Drosophila.
    Brenton JD; Ainscough JF; Lyko F; Paro R; Surani MA
    Novartis Found Symp; 1998; 214():233-44; discussion 244-50. PubMed ID: 9601021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel conserved elements upstream of the H19 gene are transcribed and act as mesodermal enhancers.
    Drewell RA; Arney KL; Arima T; Barton SC; Brenton JD; Surani MA
    Development; 2002 Mar; 129(5):1205-13. PubMed ID: 11874916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. H19 and Igf2 monoallelic expression is regulated in two distinct ways by a shared cis acting regulatory region upstream of H19.
    Srivastava M; Hsieh S; Grinberg A; Williams-Simons L; Huang SP; Pfeifer K
    Genes Dev; 2000 May; 14(10):1186-95. PubMed ID: 10817754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation of a single CTCF target site within the H19 imprinting control region leads to loss of Igf2 imprinting and complex patterns of de novo methylation upon maternal inheritance.
    Pant V; Kurukuti S; Pugacheva E; Shamsuddin S; Mariano P; Renkawitz R; Klenova E; Lobanenkov V; Ohlsson R
    Mol Cell Biol; 2004 Apr; 24(8):3497-504. PubMed ID: 15060168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory mechanisms at the mouse Igf2/H19 locus.
    Kaffer CR; Grinberg A; Pfeifer K
    Mol Cell Biol; 2001 Dec; 21(23):8189-96. PubMed ID: 11689707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel H19 antisense RNA overexpressed in breast cancer contributes to paternal IGF2 expression.
    Berteaux N; Aptel N; Cathala G; Genton C; Coll J; Daccache A; Spruyt N; Hondermarck H; Dugimont T; Curgy JJ; Forné T; Adriaenssens E
    Mol Cell Biol; 2008 Nov; 28(22):6731-45. PubMed ID: 18794369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 3' portion of the mouse H19 Imprinting-Control Region is required for proper tissue-specific expression of the Igf2 gene.
    Hagège H; Nasser R; Weber M; Milligan L; Aptel N; Jacquet C; Drewell RA; Dandolo L; Surani MA; Cathala G; Forné T
    Cytogenet Genome Res; 2006; 113(1-4):230-7. PubMed ID: 16575185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation-dependent silencing at the H19 imprinting control region by MeCP2.
    Drewell RA; Goddard CJ; Thomas JO; Surani MA
    Nucleic Acids Res; 2002 Mar; 30(5):1139-44. PubMed ID: 11861904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of CTCF binding sites in the Igf2/H19 imprinting control region.
    Szabó PE; Tang SH; Silva FJ; Tsark WM; Mann JR
    Mol Cell Biol; 2004 Jun; 24(11):4791-800. PubMed ID: 15143173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion of a silencer element in Igf2 results in loss of imprinting independent of H19.
    Constância M; Dean W; Lopes S; Moore T; Kelsey G; Reik W
    Nat Genet; 2000 Oct; 26(2):203-6. PubMed ID: 11017078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A transcriptional insulator at the imprinted H19/Igf2 locus.
    Kaffer CR; Srivastava M; Park KY; Ives E; Hsieh S; Batlle J; Grinberg A; Huang SP; Pfeifer K
    Genes Dev; 2000 Aug; 14(15):1908-19. PubMed ID: 10921905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylation sequencing analysis refines the region of H19 epimutation in Wilms tumor.
    Frevel MA; Sowerby SJ; Petersen GB; Reeve AE
    J Biol Chem; 1999 Oct; 274(41):29331-40. PubMed ID: 10506193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-random, individual-specific methylation profiles are present at the sixth CTCF binding site in the human H19/IGF2 imprinting control region.
    Tost J; Jammes H; Dupont JM; Buffat C; Robert B; Mignot TM; Mondon F; Carbonne B; Siméoni U; Grangé G; Kerjean A; Ferré F; Gut IG; Vaiman D
    Nucleic Acids Res; 2006; 34(19):5438-48. PubMed ID: 17012269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The long non-coding RNA 91H increases aggressive phenotype of breast cancer cells and up-regulates H19/IGF2 expression through epigenetic modifications.
    Vennin C; Spruyt N; Robin YM; Chassat T; Le Bourhis X; Adriaenssens E
    Cancer Lett; 2017 Jan; 385():198-206. PubMed ID: 27780718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.